Real-world effectiveness data of erenumab-treated migraine patients in Switzerland: The SQUARE study

被引：0
|
作者：
Schafer, E. [1 ]
Arzt, M. [1 ]
Meyer, I. [1 ]
Gantenbein, A. [2 ]
机构：
[1] Novartis Pharma Schweiz AG, Neurosci, Rotkreuz, Switzerland
[2] Zurzach Care, Neurol, Bad Zurzach, Switzerland
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL078
引用
收藏
页码：235 / 236
页数：2
相关论文
共 50 条
  • [1] Real-world effectiveness data of erenumab-treated migraine patients in Switzerland: The SQUARE study
    Schafer, E.
    Arzt, M.
    Meyer, I.
    Gantenbein, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2):
  • [2] The SQUARE study population: Patient characteristics of erenumab-treated patients in a real-world setting in Switzerland
    Schafer, E.
    Meyer, I.
    Arzt, M.
    Gantenbein, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 606 - 606
  • [3] Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience
    Chhabra, Nikita
    Mead-Harvey, Carolyn
    Dodoo, Christopher A.
    Iser, Courtney
    Taylor, Hallie
    Chaudhary, Hira
    Vanood, Aimen
    Dodick, David W.
    HEADACHE, 2024, 64 (03): : 233 - 242
  • [4] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    HELIYON, 2024, 10 (04)
  • [5] Real-world data on erenumab interruption in migraine patients in Germany: the SPECTRE study
    Gaul, Charly
    Goebel, Hartmut
    Koch, Mirja
    Weiss, Cordula
    CEPHALALGIA, 2023, 43 (1supp) : 232 - 233
  • [6] REAL-WORLD EFFECTIVENESS OF ERENUMAB IN CHRONIC MIGRAINE PROPHYLAXIS IN CROATIA: A PROSPECTIVE STUDY
    Bracic, Matea
    Lakusic, Darija Mahovic
    Jakus, Lukrecija
    CEPHALALGIA, 2020, 40 : 75 - 76
  • [7] Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
    Gaul, Charly
    Gendolla, Astrid
    Holle, Dagny
    Goebel, Hartmut
    Koch, Mirja
    Baufeld, Caroline
    Weiss, Cordula
    PAIN AND THERAPY, 2024, 13 (06) : 1659 - 1678
  • [8] A real-world, observational study of erenumab for migraine prevention in Canadian patients
    Becker, Werner J.
    Spacey, Sian
    Leroux, Elizabeth
    Giammarco, Rose
    Gladstone, Jonathan
    Christie, Suzanne
    Akaberi, Arash
    Power, G. Sarah
    Minhas, Jagdeep K.
    Mancini, Johanna
    Rochdi, Driss
    Filiz, Ayca
    Bastien, Natacha
    HEADACHE, 2022, 62 (04): : 522 - 529
  • [9] Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data
    Dodick, David W.
    Tepper, Stewart J.
    Ailani, Jessica
    Pannacciulli, Nicola
    Navetta, Marco S.
    Loop, Brett
    Zhang, Feng
    Khodavirdi, Ani C.
    Mann, Allison
    Abdrabboh, Ahmad
    Kalim, Jawed
    HEADACHE, 2021, 61 (09): : 1411 - 1420
  • [10] Effectiveness and safety of erenumab in chronic migraine: A Croatian real-world experience
    Mahovic, Darija
    Bracic, Matea
    Jakus, Lukrecija
    Cvetkovic, Vlasta Vukovic
    Krpan, Marina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 214
12345